During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant ...

In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by ...

CellProthera says it chose CELLforCURE by SEQENS as its CDMO for the quality of its infrastructure, equipment, and expertise of its team.

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

An unprecedented international effort to decode how cells manage the transport of chemical substances has culminated in four groundbreaking studies This decade-long project provides the first ...

Methods: We investigated the role of MerTK expression in TNBC using syngeneic and immunodeficient mouse models, human and murine cells lines, and human clinical samples. Flow cytometry, ...

Access includes Asimov’s CHO Edge cell line development platform and Cytiva’s HyClone™ media and feed solutions, along with Cytiva’s Fast Trak™ process development services.

LOS ANGELES — Living-related conjunctival limbal allograft should be first-line therapy for limbal stem cell deficiency, Edward J. Holland, MD, said during Cornea Day at the American Society of ...

The HEK293T cell line was cultured in Dulbecco’s modified DMEM medium (BI, Göttingen, Germany). HGC-27, MB-231, and 5637 cells were maintained in RPMI-1640 medium (Biosera, Cholet, France). SW780 and ...

Adaptive NK cells have memory powers that make them fierce cancer fighters, with promising results especially for ovarian cancer and future immunotherapies. Credit: SciTechDaily.com Natural killer ...